Physician

Francisco Javier Jimenez Carcamo, MD

According to 2025 Medicare claims, Francisco Carcamo, MD (NPI: 1295787927) practices advanced heart failure and transplant cardiology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE ASSOCIATES PA (NPI: 1831123520; TIN: 65-0511644) and primary practice location at 33143-4829. Carcamo is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Carcamo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 547 traditional Medicare patients, billed 4,342 HCPCS/CPT codes, and received $283,371 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,903 prescription claims across 777 beneficiaries totaling $9,881,138 in drug costs, led by Opsumit (Macitentan). DME data shows 192 claims. Open Payments data shows 51 records totaling $15,185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,939,636 to $9,881,138. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $47,142 to $10,029.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,468	4,282	$252,561
2016	1,131	3,424	$229,718
2017	1,160	3,594	$229,603
2018	972	3,461	$217,749
2019	999	3,648	$226,055
2020	813	3,427	$170,011
2021	751	4,003	$238,311
2022	802	5,082	$275,343
2023	723	4,817	$317,394
2024	547	4,342	$283,371

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	447	6,993	$2,939,636
2016	510	8,007	$4,906,121
2017	583	7,891	$6,530,866
2018	681	7,783	$8,624,058
2019	702	6,915	$7,511,275
2020	688	7,043	$8,533,610
2021	697	6,865	$8,737,783
2022	771	7,033	$8,317,060
2023	778	7,067	$8,401,179
2024	777	6,903	$9,881,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	530	$645,246
2016	16	845	$472,085
2017	N/R	606	$37,039
2018	11	458	$20,344
2019	N/R	631	$264,023
2020	N/R	359	$313,759
2021	N/R	291	$133,196
2022	N/R	343	$112,827
2023	N/R	241	$174,838
2024	N/R	192	$346,654

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	192	195	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	315	597	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	312	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	211	349	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	268	345	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	211	6,307	$2,662,176
Adempas	Riociguat	80	2,377	$1,135,416
Orenitram Er	Treprostinil Diolamine	85	2,379	$1,035,308
Vyndamax	Tafamidis	30	1,140	$873,821
Uptravi	Selexipag	29	832	$700,337

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7686	Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg	N	N/R	13	$211,807
J3285	Injection, treprostinil, 1 mg	N	N/R	16	$126,580
K0455	Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)	Y	N/R	15	$3,816
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	17	$1,101
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,028

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$15,185	Actelion Pharmaceuticals US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Francisco Javier Jimenez Carcamo, MD?

Tedicare shows public-source Medicare data for Francisco Javier Jimenez Carcamo, MD (NPI 1295787927), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Francisco Javier Jimenez Carcamo, MD have ACO affiliation data?

Francisco Javier Jimenez Carcamo, MD is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Francisco Javier Jimenez Carcamo, MD?

Francisco Javier Jimenez Carcamo, MD is linked to CARDIOVASCULAR MEDICINE ASSOCIATES PA (billing NPI 1831123520) in the available physician profile data.

Does Francisco Javier Jimenez Carcamo, MD have Open Payments data?

Francisco Javier Jimenez Carcamo, MD has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.